Literature DB >> 18045727

Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.

Ikuhiko Nakase1, Toshihide Takeuchi, Gen Tanaka, Shiroh Futaki.   

Abstract

Peptides including HIV-1 Tat peptide and oligoarginines represent arginine-rich membrane-permeable vectors that attain efficient intracellular delivery of bioactive molecules. The importance of the arginine residues or their guanidino functions is now appreciated for efficient internalization of the Tat peptide, and based on this, various novel arginine/guanidino-rich vectors have now been developed. However, molecular detail of their method(s) of internalization are still debated. This review summarizes our current understandings of endocytic and non-endocytic aspects of internalization of arginine-rich peptide vectors. We highlight the possibility of simultaneous employment of multiple internalization pathways, the contribution of which is dependent on a number of factors. Similarities and dissimilarities among the internalization methods of typical peptide vectors and other guanidino-rich vectors including branched-chain, beta-peptide, and sugar-based vectors, are also discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045727     DOI: 10.1016/j.addr.2007.10.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  69 in total

1.  Targeting a ruthenium complex to the nucleus with short peptides.

Authors:  Cindy A Puckett; Jacqueline K Barton
Journal:  Bioorg Med Chem       Date:  2010-04-08       Impact factor: 3.641

Review 2.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 3.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

4.  Generation of endosomolytic reagents by branching of cell-penetrating peptides: tools for the delivery of bioactive compounds to live cells in cis or trans.

Authors:  Alfredo M Angeles-Boza; Alfredo Erazo-Oliveras; Ya-Jung Lee; Jean-Philippe Pellois
Journal:  Bioconjug Chem       Date:  2010-11-02       Impact factor: 4.774

5.  The Late Endosome and Its Lipid BMP Act as Gateways for Efficient Cytosolic Access of the Delivery Agent dfTAT and Its Macromolecular Cargos.

Authors:  Alfredo Erazo-Oliveras; Kristina Najjar; Dat Truong; Ting-Yi Wang; Dakota J Brock; Austin R Prater; Jean-Philippe Pellois
Journal:  Cell Chem Biol       Date:  2016-05-05       Impact factor: 8.116

6.  Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide.

Authors:  Misao Akishiba; Toshihide Takeuchi; Yoshimasa Kawaguchi; Kentarou Sakamoto; Hao-Hsin Yu; Ikuhiko Nakase; Tomoka Takatani-Nakase; Fatemeh Madani; Astrid Gräslund; Shiroh Futaki
Journal:  Nat Chem       Date:  2017-05-22       Impact factor: 24.427

7.  Cellular Uptake of A Taurine-Modified, Ester Bond-Decorated D-Peptide Derivative via Dynamin-Based Endocytosis and Macropinocytosis.

Authors:  Jie Zhou; Xuewen Du; Cristina Berciu; Steven J Del Signore; Xiaoyi Chen; Natsuko Yamagata; Avital A Rodal; Daniela Nicastro; Bing Xu
Journal:  Mol Ther       Date:  2018-01-06       Impact factor: 11.454

8.  A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging.

Authors:  Ye Yuan; Yixuan He; Ruonan Bo; Zhao Ma; Zhongling Wang; Lijie Dong; Tzu-Yin Lin; Xiangdong Xue; Yuanpei Li
Journal:  Nanoscale       Date:  2018-11-29       Impact factor: 7.790

9.  Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction.

Authors:  Jacob M Gump; Ronald K June; Steven F Dowdy
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.